My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 483

    1.

    Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

    Diabetes Care. 2003 Sep;26(9):2598-603.PMID: 12941725 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

    Diabetes Care. 2004 Jul;27(7):1554-8.PMID: 15220227 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

    Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

    Diabetes Care. 2005 Jul;28(7):1568-73.PMID: 15983302 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

    Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

    Diabetes Care. 2005 Mar;28(3):533-8.PMID: 15735183 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

    Diabetes Care. 2009 Jul;32(7):1170-6. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944. PMID: 19389820 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

    Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

    Diabetes Technol Ther. 2005 Aug;7(4):587-96.PMID: 16120030 [PubMed - indexed for MEDLINE]Related articles

    8.

    Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

    Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

    Diabetologia. 2008 Jun;51(6):941-51. Epub 2008 Mar 20. Review.PMID: 18351320 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

    Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

    Pediatrics. 2003 Sep;112(3 Pt 1):559-64.PMID: 12949284 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.

    Weinzimer SA, Ternand C, Howard C, Chang CT, Becker DJ, Laffel LM; Insulin Aspart Pediatric Pump Study Group.

    Diabetes Care. 2008 Feb;31(2):210-5. Epub 2007 Nov 5.PMID: 17989308 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.

    Diabet Med. 2008 Mar;25(3):326-32.PMID: 18307459 [PubMed - indexed for MEDLINE]Related articles

    12.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.

    Bode BW.

    Clin Ther. 2007;29 Suppl D:S135-44.PMID: 18191065 [PubMed - indexed for MEDLINE]Related articles

    14.

    Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.

    Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L.

    Adv Med Sci. 2006;51:133-6.PMID: 17357293 [PubMed - indexed for MEDLINE]Related articles

    15.

    Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.

    Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J.

    Pediatr Diabetes. 2008 Oct;9(5):472-9. Epub 2008 Aug 20.PMID: 18721168 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Effectiveness of selected methods of the short-term intensive insulin therapy in patients with poorly controlled type 2 diabetes mellitus]

    Ruxer J, Mozdzan M, Czupryniak L, Saryusz-Wolska M, Loba J.

    Pol Arch Med Wewn. 2004 Aug;112(2):945-52. Polish. PMID: 15675270 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.

    Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I, Harman-Boehm I.

    Diabet Med. 2005 Aug;22(8):1037-46.PMID: 16026370 [PubMed - indexed for MEDLINE]Related articles

    18.

    Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

    Bode BW, Steed RD, Schleusener DS, Strange P.

    Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

    19.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    20.

    Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.

    Pickup JC, Kidd J, Burmiston S, Yemane N.

    Diabetes Metab Res Rev. 2006 May-Jun;22(3):232-7.PMID: 16389648 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity